Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. - Wikidata - awgldk - TriplyDB

Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.

Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.

http://www.wikidata.org/entity/Q42279683

about

Current Treatment Approaches to HCC with a Special Consideration to Transplantation Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients Donations After Circulatory Death in Liver Transplant.Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study.The role of hepatic ischemia-reperfusion injury and liver parenchymal quality on cancer recurrence.Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation.Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis.Current challenges and future directions for liver transplantation.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Race not rural residency is predictive of surgical treatment for hepatocellular carcinoma: Analysis of the Texas Cancer Registry.Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma.The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma.PARP-1 promotes tumor recurrence after warm ischemic liver graft transplantation via neutrophil recruitment and polarization.Recurrent malignancy: Are we pushing the envelope?A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation.Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors.Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation.

P2860

Q26740375-FFEB62C6-C620-405C-91BE-6215A081ABD4 Q26766049-2CF26CF3-AA9F-4477-9A24-D5D44547B9ED Q33771943-4B5B1C3D-4ED3-4271-AE1F-1CD8E4370451 Q35020079-3BB2C6E0-FC1E-421D-B0B0-60E5ECF9B39E Q36962089-2219A23A-DE5C-4381-84B8-2CB0FE6B7F2D Q38202916-8372228E-5A05-40EE-AE61-48E481539689 Q38209283-1740A9FB-393C-47E0-BEDB-078F77A0DB4F Q38237510-E0BB3DD9-868D-4757-9C33-6AA849511257 Q38568533-8EA13F9A-4320-4AE8-B3E9-A2EA6821B1B7 Q38635611-9D4197A7-13AF-46D4-900B-B8BF712B1DFB Q38793018-D8CECDBE-374C-43A2-8459-BBC2CE4C4D3A Q38820685-EE1FD196-00A6-44D4-9453-91EF7ED5BD66 Q39067623-DDD115A6-5033-455B-B4DE-960F854A582F Q40179581-21F12432-8ECB-4671-843D-299C58054007 Q40235716-CC4C028A-EA67-4A16-8117-C6319FDD5C50 Q41742206-54690992-3376-4945-8177-2E48FEAA1442 Q47156777-69137D6F-CDE2-4DAA-A385-6807FE4C737B Q48188591-E9B9B8B9-3266-4ED3-A846-E35BD4EFAFCF Q48643260-29CB3117-06D1-4D5E-9C64-979F352E8869 Q51750927-E9F9C36C-0367-4DE9-8975-130A1B3E955A Q53028734-2CB1C014-2C14-4C43-8A83-C92D718268B5 Q55275430-0AB42155-2052-4A83-ADB4-52CE932F850E

P2860

Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.

http://www.wikidata.org/entity/Q42279683

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Inferior survival in liver tra ...... ardiac death liver allografts.

@en

Inferior survival in liver tra ...... ardiac death liver allografts.

@nl

type

label

Inferior survival in liver tra ...... ardiac death liver allografts.

@en

Inferior survival in liver tra ...... ardiac death liver allografts.

@nl

prefLabel

Inferior survival in liver tra ...... ardiac death liver allografts.

@en

Inferior survival in liver tra ...... ardiac death liver allografts.

@nl

P1433

Q42279683-F4AD5901-2B9F-4F42-BE25-08FEA4C8346A

P1476

Q42279683-E72CCC28-D625-4F1F-A27D-263F0ECF9C8D

P2093

Q42279683-609637DB-8C85-4B76-8CF1-6D54214EB8D3

Q42279683-91224AC0-04E7-44D1-B593-A182CD6B201D

Q42279683-C5BB68B0-98D5-43EB-9508-9A2E5DE7E160

Q42279683-C95AF1C8-ED25-4200-9E34-BF13F954411E

Q42279683-F361D29E-8A61-4A33-A6ED-8C721CD22369

Q42279683-F8A73ECD-86B3-48B4-8884-9511869F329B

P2860

Q42279683-07B8BC22-9790-4606-9D5A-693FBC8B2F8C

Q42279683-0CF79AFC-DDE8-4109-BE62-E917980B5033

Q42279683-0EA7B17F-9DB5-470F-8BC2-F2B571377288

Q42279683-154E30B8-9934-427A-AE80-FF25DC7551BE

Q42279683-50A7C8F6-1501-468B-9D48-B51075DEE357

Q42279683-698B8DFF-900E-4BF7-A1B6-68DF7540719B

Q42279683-7CEE5F20-56BE-47DD-A6B0-4841C1D61E71

Q42279683-8B484517-33A4-4337-91AA-3C60C4D928B9

Q42279683-9290F8F1-0211-4F15-895D-645B8A9968C5

Q42279683-97BFCE0F-FD0B-43B0-9D5D-25B0F53EBED2

P304

Q42279683-69A9B1A2-B64E-4AB1-99B9-E27282C85B93

P31

Q42279683-74D46CC4-87D6-4B02-95B6-99D9465A42D6

P356

Q42279683-D5677F4E-8BB7-44BD-9E0D-AC80CC1FE01E

P433

Q42279683-6BFB49C0-E407-4C93-91A7-4D62808FD77D

P478

Q42279683-3B8130E6-F673-4A48-A4F6-A7A3564C2479

P577

Q42279683-793B45A2-7F88-43A2-B8FB-44DF5071FEB0

P698

Q42279683-D6B3414F-59C1-46D6-AFDE-0BACB220059B

P356

P1433

Liver Transplantation

P1476

Inferior survival in liver tra ...... ardiac death liver allografts.

@en

P2093

Gavin Beck

http://www.w3.org/2001/XMLSchema#string

Kris P Croome

http://www.w3.org/2001/XMLSchema#string

Natasha Chandok

http://www.w3.org/2001/XMLSchema#string

Paul Marotta

http://www.w3.org/2001/XMLSchema#string

Roberto Hernandez-Alejandro

http://www.w3.org/2001/XMLSchema#string

William Wall

http://www.w3.org/2001/XMLSchema#string

P2860

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.

Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN/UNOS data.

Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.

Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning.

A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry.

Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit.

Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.

Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.

Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility.

P304

1214-1223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LT.23715

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23907778

http://www.w3.org/2001/XMLSchema#string